Inhibition of platelet aggregation by a protein factor present in rat peripheral polymorphonuclear leukocyte supernatant

Thrombosis Research

Volumn 91, Issue 2, 1998, Pages 75-82

  Kumari, R ^a   Singh, M P ^a   Seth, P ^a   Dikshit, M ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Platelet aggregation; PMNLs derived inhibitory factor; PMNLs supernatant; Polymorphonuclear leukocytes (PMNLs); Protease

Indexed keywords

ADENOSINE DIPHOSPHATE; ARACHIDONIC ACID; CALCIUM IONOPHORE; NITRIC OXIDE;

ARTICLE; HUMAN; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN PURIFICATION; THROMBOCYTE AGGREGATION;

ADENOSINE DEAMINASE; ADENOSINE DIPHOSPHATE; ANIMALS; ARACHIDONIC ACID; CALCIMYCIN; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; MACACA MULATTA; MALE; METHYLENE BLUE; NEUTROPHILS; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; SERINE PROTEINASE INHIBITORS; TEMPERATURE; TIME FACTORS;

EID: 0032528123     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(98)00052-8     Document Type: Article

References (33)

1. Cerletti C, Evangelista V, de Gaetano G. Polymorphonuclear leukocyte-dependent modulation of platelet function. Relevance to the pathogenesis of thrombosis. Pharmacol Res 1992;26:261-8.
2. Renesto P, Chignard M. Neutrophil-mediated platelet activation: A key role for serine proteinases. Gen Pharmacol 1995;26:905-10.
3. Dikshit M, Kumari R. Modulation of platelet aggregation response by factors released from polymorphonuclear leukocytes. Hematology 1997;2:39-53.
4. Bykowska K, Kaczanowska J, Karpowicz M, Stachurska J, Kopic M. Effect of neutral proteases from blood leukocytes on human platelets. Thromb Haemostasis 1993;50:768-72.
5. Kornecki F, Ehrlich YH, Egbring R, Gramse M, Stitz R, Eckardt A, Lukasiewicz H, Niewiarowski S. Granulocyte-platelet interaction and fibrinogen receptor exposure. Am J Physiol 1988;255:H651-8.
6. Selak MA, Chignard M, Smith JB. Cathepsin G is a strong platelet agonist released by neutrophils. Biochem J 1988;251:293-9.
7. Canoso RT, Rodview R, Scoon K, Levine PH. Hydrogen peroxide and platelet function. Blood 1974;43:645-56.
8. Handin LI, Karabin R, Boxer GJ. Enhancement of platelet function by superoxide anions. J Clin Invest 1977;59:959-65.
9. Oda M, Satouchi K, Yasunaga K, Saito K. Polymorphonuclear leukocyte-platelet interactions: Acetylglyceryl ether phosphocholine-induced platelet activation under stimulation with chemotactic peptide. J Biochem 1986;100:1117-23.
10. Coeffier E, Joseph D, Prevost MC, Vargaftig B. Platelet-leukocyte interaction: activation of rabbit platelets by FMLP-stimulated neutrophils. Brit J Pharmacol 1987;92:393-406.
11. Oudinet JP, Sraer J, Bens M, Ardaillou R. Influence of polymorphonuclear leukocytes on the metabolism of arachidonate in human platelets. Thromb Haemostasis 1988;60:59-62.
12. Zatta A, Pandolfo L, Caparrotta L, Prosdocimi M, Dejana E, Del Maschio A. Platelet aggregation induced by the endoperoxide analogue U 46619 is inhibited by polymorphonuclear leukocyte ADPase activity. Arterioscler Thromb 1993;13:696-701.
13. Rimele TJ, Strum RJ, Adams LM, Henry DE, Heaslip RJ, Weichman BM, Grimes D. Interaction of neutrophils with vascular smooth muscle: Identification of a neutrophil derived relaxing factor. J Pharmacol Exp Ther 1988; 245:102-11.
14. Salvemini D, De Nucci G, Gryglewski RJ, Vane JR. Human neutrophils and mononuclear cells inhibit platelet aggregation by releasing a nitric oxide like factor. Proc Natl Acad Sci USA 1989;86:6328-32.
15. Dikshit M, Kumari R, Srimal RC. Pulmonary thromboembolism induced alterations in nitric oxide release from rat circulating neutrophils. J Pharmacol Exp Ther 1993;265:1369-72.
16. Liu JJ, Chen JR, Wiley J, Johnston CI, Buxton BF. Inhibition by a stable factor derived from neutrophils of endothelium dependent relaxation in rat aorta. Am J Physiol 1993;265: H1454-9.
17. Liu JJ, Chen JR, Bradley CJ, Xie B, Johnston CI, Buxton BF. Autologous neutrophil derived supernatant inhibit endothelium dependent relaxation in human coronary bypass graft. Cardiovasc Res 1994;28:1353-9.
18. 2+ signaling and possible exocytosis in endothelial cells by a stable leukocyte derived factor. Biochem Biophys Res Commun 1995;206:146-52.
19. Liu JJ, Xie B, Smith IL, Johnston CI, Buxton BF. A stable leukocyte-derived factor inhibits platelet aggregation. Biochem Biophys Res Commun 1994;201:878-82.
20. Seth P, Kumari R, Dikshit M, Srimal RC. Modulation of rat peripheral polymorphonuclear leukocyte response by nitric oxide and arginine. Blood 1994;84:2741-8.
21. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with folin-phenol reagent. J Biol Chem 1955;193:265-75.
22. Babior BM, Kiphes RS, Girnutte JT. Biological defense mechanisms. The production by leukocytes of superoxide a potential bactericidal agent. J Clin Invest 1973;52:741-4.
23. Faint RW, Mackie IJ, Machin SJ. Platelet aggregation is inhibited by a nitric oxide like factor released from human neutrophils in vitro. Brit J Haematol 1991;77:539-45.
24. Levine PH, Weingner RS, Simon J, Scoon KL, Krinsky NI. Leukocyte-platelet interaction: Release of hydrogen peroxide by granulocytes as a modulator of platelet reactions. J Clin Invest 1976;57:955-63.
25. Koufos A, Sagone AL, Jr. Effects of oxidant stress on the hexose-monophosphate shunt pathway of platelets. Blood 1980;55:835-40.
26. Pryor WA. Oxy-radicals and related species: Their formation, life times and reactions. Ann Rev Physiol 1986;48:657-67.
27. Martin W, Villani GM, Jothlanandan D, Furchgott RF. Selective blockade of endotheliumdependent and glyceryl tri nitrate induced relaxation by hemoglobin and methylene blue in the rabbit aorta. J Pharmacol Exp Ther 1985; 232:708-16.
28. Mazoyer E, Levy-Toledano S, Rendu F, Hermant L, Lu H, Fiat AM, Jolles P, Caen J. KRDS, a new peptide derived from human lectotransferrin inhibits platelet-aggregation and release reaction. Eur J Biochem 1990; 194:43-9.
29. Qian Z-Y, Jolles P, Migliore-Samour D, Fiat AM. Isolation and characterization of sheep lactoferrin, an inhibitor of platelet aggregation and comparison with human lactoferrin. Biochim Biophys Acta 1995;1243:25-32.
30. Borregaard M, Miller LJ, Spinger TA. Chemoattractant-regulated mobilization of a novel intracellular compartment in human neutrophils. Science 1987;237:1204-6.
31. Renesto P, Chignard M. Tumor necrosis factor α enhances platelet activation via Cathepsin G released from neutrophils. J Immunol 1991; 146:2305-9.
32. Renesto P, Si-Tahar M, Moniatte M, Balloy V, Dorsselaer AV, Pidard D, Chignard M. Specific inhibition of thrombin induced cell activation by neutrophil proteinases elastase, cathepsin G and proteinase 3: Evidence for distinct cleavage sites within the aminoterminal domain of the thrombin receptor. Blood 1997; 89:1944-53.
33. Renesto P, Balloy V, Chignard M. Inhibition by human elastase of neutrophil-mediated platelet activation. Eur J Pharmacol 1994;248: 151-5.